ICCD

600+ cybersecurity experts meet at PhilSec 2022 to discuss the future of cybersecurity in the Philippines

Retrieved on: 
Thursday, August 11, 2022
Zero, DDLS, Sofitel Philippine Plaza Manila, Critical infrastructure, CPPD, Industry, Okta, ExtraHop Networks, Common Law Admission Test, Compliance, Technology, Growth, IPV, Digital forensics, BeyondTrust, Monitoring, The Department, Bell–LaPadula model, DICT, Coordination, CISO, ICCD, Unknown, Risk, Communication, CrowdStrike, Friends, Department of Information and Communications Technology, CICC, Solution, Forensic science, Organization, Medical device, Risk management, Tenable, Meralco, Synology, Information, CyberArk, Policy, Swim lane

Here's what she had to say when talking about her experience at PhilSec 2022, "This is my first time back on-stage post pandemic.

Key Points: 
  • Here's what she had to say when talking about her experience at PhilSec 2022, "This is my first time back on-stage post pandemic.
  • With the most carefully curated agenda that comprised advanced topics in cybersecurity, PhilSec 2022 also hosted over 40 of the best cybersecurity experts and thought leaders who had a spellbinding effect on the delegates with their knowledge sharing sessions.
  • Apart from the knowledge sharing and networking sessions, PhilSec 2022 also acknowledged the top talents from Philippines' cybersecurity during the awards segment, PhilSec Awards 2022.
  • As a deal facilitator, Tradepass is always determined about exposing the most agile liquid growth markets, to enable all-round scalability and growth.

StrikeReady Named 2022 SIIA CODiE Award Finalist for Best Emerging Technology

Retrieved on: 
Tuesday, April 26, 2022
Internet, Security, Data Management, Technology, Software, ICCD, CEO, Technology, Software, CARA, FireEye, Leadership, Awareness, Automation, Organization, Education, Efficiency, Software and Information Industry Association, Publishing, Computer security, Solution, Artificial intelligence, Security, Year, SIIA, Globe Telecom, Multimedia, CB, CrowdStrike, Software as a service, Time, Association, Knowledge, Medical device, Video game, Risk management, Weapon, San Francisco Bay Area

An AI-driven security company, StrikeReady today announced that CARA was named a 2022 SIIA CODiE Award finalist in the Best Emerging Technology category.

Key Points: 
  • An AI-driven security company, StrikeReady today announced that CARA was named a 2022 SIIA CODiE Award finalist in the Best Emerging Technology category.
  • View the full release here: https://www.businesswire.com/news/home/20220426005405/en/
    StrikeReady Named 2022 SIIA CODiE Award Finalist for Best Emerging Technology (Graphic: Business Wire)
    According to the 2022 CODiE Award judge, StrikeReady, CARA is the only software solution in this competition that has demonstrated incorporating the principles of Intelligent Configuration, Customization, and Design (ICCD) into its product offering.
  • "We are thrilled to be recognized in this very competitive category as Best Emerging Technology Finalist for CARA - Cyber Awareness and Response Analyst," said Yasir Khalid, CEO of StrikeReady.
  • StrikeReady has won numerous awards and mentions in the short time that it has been in existence, including 2022 CODiE Finalist Best Emerging Technology, 2022 Artificial Intelligence Excellence Awards, 2022 Cyber Security Global Excellence Awards, 2022 Cybersecurity Excellence Awards, 2021 CyberSecured Awards, American Security Today 'ASTORS' Homeland Security Award 2021, Security Today's Product of the Year Award 2021, Globee's Disruptor Award 2021, and CB Insights 2021 Cyber Defender.

Teledyne Princeton Instruments announces new series of CCD cameras for Original Equipment Manufacturers

Retrieved on: 
Tuesday, March 29, 2022
Indium gallium arsenide, Teledyne Technologies, Raman, NYSE, OES, SCMOS, EMCCD, ICCD, Original equipment manufacturer, CCD, OEM, TDY, Software, Documentation, GLOBE, Drug discovery, Fluorescence, Medical imaging, Video game console

TRENTON, N.J., March 29, 2022 (GLOBE NEWSWIRE) -- Teledyne Princeton Instruments, a Teledyne Technologies [NYSE: TDY] company, announces the release of LANSIS a new spectroscopy detector designed specifically for original equipment manufacturers (OEM) and system integrators.

Key Points: 
  • TRENTON, N.J., March 29, 2022 (GLOBE NEWSWIRE) -- Teledyne Princeton Instruments, a Teledyne Technologies [NYSE: TDY] company, announces the release of LANSIS a new spectroscopy detector designed specifically for original equipment manufacturers (OEM) and system integrators.
  • LANSIS cameras represent the latest in CCD array detector technology specifically tailored to OEMs.
  • Some features specific to LANSIS include:
    Easy System Integration: A variety of mounting configurations makes integration of cameras fast and easy.
  • Teledyne Princeton Instruments, a part of Teledynes Vision Solutions Group, designs and manufactures high-performance CCD, sCMOS, ICCD, EMCCD, emICCD, and InGaAs cameras; spectrographs; and optics-based solutions for the scientific research, industrial imaging, and OEM communities.

Lantern Pharma Expands into Additional Pediatric Cancers Through a Collaboration with The Greehey Children's Cancer Research Institute (GCCRI) at University of Texas Health Science Center-San Antonio

Retrieved on: 
Tuesday, February 15, 2022
NASDAQ, ATRT, A.I, Patient, ADC, Drug resistance, UTHSCSA, Cancer, Food, Biomarker, CEO, Sarcoma, National Cancer Institute, ICCD, Greehey Children's Cancer Research Institute, University, Cancer Research Institute, Ewing's sarcoma, Goal, Clinical trial, Pancreatic cancer, Rhabdomyosarcoma, Glioma, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Therapy, Neoplasm, FDA, Survival, Wilms' tumor, Glioblastoma, Child, Central nervous system, MRT, Machine learning, Research, DNA, Drug discovery, Gaps, Probability, Drug development, Pharmaceutical industry, Medical imaging, Lantern, PDX

drug discovery platform into additional rare pediatric cancers through a collaboration with The Greehey Children's Cancer Research Institute (GCCRI) at the University of Texas Health Science Center at San Antonio (UTHSCSA) .

Key Points: 
  • drug discovery platform into additional rare pediatric cancers through a collaboration with The Greehey Children's Cancer Research Institute (GCCRI) at the University of Texas Health Science Center at San Antonio (UTHSCSA) .
  • GCCRI is one of only two research institutions in the United States focused exclusively on pediatric cancer research and therapy development.
  • The research collaboration between Lantern Pharma and the GCCRI will be led by Dr. Peter Houghton , the former director of the GCCRI.
  • The announcement of the collaboration between Lantern Pharma and the GCCRI comes on International Childhood Cancer Research Day (ICCD).